We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

New, Highly Purified Mycoplasma Pneumoniae Native Antigen


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New, Highly Purified Mycoplasma Pneumoniae Native Antigen"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Native Antigen Company (NAC) has announced the release of a highly purified Mycoplasma pneumoniae native antigen.

M pneumoniae is recognized as one of the most common causes of community-acquired pneumonia.

Early diagnosis of M.pneumoniae, usually by an ELISA IgM assay, is important because the infection often responds well to appropriate antibiotics.

However, ELISA assays, particularly those for IgM detection, often exhibit poor sensitivity and may, in addition, be susceptible to cross reactivity from other pathogens.

The company claims that its new purified antigen preparation, which is highly reactive to IgM, will offer in-vitro diagnostic (IVD) manufacturers the opportunity to introduce next generation ELISA assays which demonstrate greater specificity set against an inherently low background signal.

Advertisement